HC Q ex vivo study
See all studies
5/8
Ex Vivo
Ex Vivo
Grassin-Delyle et al., Clinical Infectious Diseases, doi:10.1093/cid/ciaa546 (Peer Reviewed) (Ex Vivo) (not included in the study count)
Ch loroquine Inhibits the Release of Inflammatory Cytokines by Human Lung Explants
On human lung parenchymal explants, C Q concentration clinically achievable in the lung (100 µM) inhibited the lipopolysaccharide-induced release of TNF-ɑ (by 76%), IL-6 (by 68%), CCL2 (by 72%), and CCL3 (by 67%). In addition to antiviral activity, C Q may also mitigate the cytokine storm associated with severe pneumonia caused by coronaviruses.
Source   Share   Tweet
See all studies
Please send us corrections, updates, or comments.
Submit